- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Updates, 30-03-2026: Press Release
30-03-2026 | 08:58 am
30-03-2026 | 08:58 am
Wockhardt's Zaynich® (Zidebactam/Cefepime) received a positive opinion from CDSCO's expert committee for Gram-negative infections. This moves it closer to final approval, addressing a critical global unmet medical need.
No comments yet. Be the first to comment!